Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Lane

Showing results (181-190 of 259) with videos related to

Pageof 26
Sort By:
Histopathology|October 1, 1992
p53 expression is common in malignant mesotheliomaG Kafiri, D M Thomas, N A Shepherd, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|April 28, 2000
Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector PenetratinP M Fischer, N Z Zhelev, S Wang, et al.
Lancet (London, England)|August 24, 1991
p53 immunostaining as a marker of malignant disease in diagnostic cytopathologyP A Hall, A Ray, N R Lemoine, et al.
Journal of Clinical Pathology|August 1, 1991
Prognostic value of proliferating cell nuclear antigen in gastric carcinomaS Jain, M I Filipe, P A Hall, et al.
Nature|February 7, 1991
Requirement for the replication protein SSB in human DNA excision repairD Coverley, M K Kenny, M Munn, et al.
Gastroenterology|December 1, 1992
Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalizationM R Gray, P A Hall, J Nash, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|January 30, 1995
On the regulation of the p53 tumour suppressor, and its role in the cellular response to DNA damageD P Lane, C A Midgley, T R Hupp, et al.
Oncogene|July 25, 2012
C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balancesP Muller, E Ruckova, P Halada, et al.
British Journal of Cancer|June 1, 1995
Absence of p53 autoantibodies in a significant proportion of breast cancer patientsB Vojtesek, J Kovarik, H Dolezalova, et al.
Oncogene|December 1, 1991
Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid miceP A Burns, C J Kemp, J V Gannon, et al.
Pageof 26

Showing results (181-190 of 259) with videos related to

Sort By:
Pageof 26
Histopathology|October 1, 1992
p53 expression is common in malignant mesotheliomaG Kafiri, D M Thomas, N A Shepherd, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|April 28, 2000
Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector PenetratinP M Fischer, N Z Zhelev, S Wang, et al.
Lancet (London, England)|August 24, 1991
p53 immunostaining as a marker of malignant disease in diagnostic cytopathologyP A Hall, A Ray, N R Lemoine, et al.
Journal of Clinical Pathology|August 1, 1991
Prognostic value of proliferating cell nuclear antigen in gastric carcinomaS Jain, M I Filipe, P A Hall, et al.
Nature|February 7, 1991
Requirement for the replication protein SSB in human DNA excision repairD Coverley, M K Kenny, M Munn, et al.
Gastroenterology|December 1, 1992
Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalizationM R Gray, P A Hall, J Nash, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|January 30, 1995
On the regulation of the p53 tumour suppressor, and its role in the cellular response to DNA damageD P Lane, C A Midgley, T R Hupp, et al.
Oncogene|July 25, 2012
C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balancesP Muller, E Ruckova, P Halada, et al.
British Journal of Cancer|June 1, 1995
Absence of p53 autoantibodies in a significant proportion of breast cancer patientsB Vojtesek, J Kovarik, H Dolezalova, et al.
Oncogene|December 1, 1991
Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid miceP A Burns, C J Kemp, J V Gannon, et al.
Pageof 26